Julie McElrath, MD, PhD

Senior Vice President / Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center, Vaccines & Infectious Disease 1100 Eastlake Ave E, E5-110 Seattle, WA 98109

Dr. Julie McElrath is a Senior Vice President and Member of Fred Hutchinson Cancer Research Center where she directs the Vaccine and Infectious Disease Division and holds the Joel Meyers Endowed Chair.


Dr. McElrath is a key scientific leader in the development of a clinically effective HIV vaccine. She has mentored numerous junior PhD and MD faculty, young investigators and graduate students in their career paths.

Training and Education

  • 1980
    MD, Medical University of South Carolina
  • 1978
    PhD, Experimental Pathology, Medical University of South Carolina
  • 1983
    Residency, Internal Medicine, Medical University of South Carolina
  • 1985
    Fellowship, Infectious Diseases, Columbia Presbyterian Medical Center
  • 1988
    Postdoctoral Fellowship, Cell Physiology & Immunology, Rockefeller University

Research Interests

Julie McElrath established a global laboratory platform to elucidate immunity and protective correlates of an effective HIV vaccine, serving as a framework for pathogen vaccines of public health importance.

Related to this effort, she is the Principal Investigator of the HIV Vaccine Trials Network Laboratory Center & the Seattle Vaccine Unit funded by the National Institutes of Health and the Bill and Melinda Gates Foundation Adjuvant CAVD.

Her translational research pursues both a vaccine that will protect against HIV infection and a deeper understanding of the components of immunity that contribute to control of HIV disease.